Normal Ferritin Level for Hair Loss Evaluation
There is no universally established "normal" ferritin threshold for hair loss, but current evidence suggests targeting serum ferritin levels ≥40-70 ng/mL when evaluating patients with hair loss, with the most recent data supporting ≥60 ng/mL as optimal for hair growth.
Evidence-Based Ferritin Thresholds
The relationship between ferritin and hair loss remains controversial, but specific thresholds have emerged from clinical studies:
Key Threshold Recommendations
≥70 ng/mL: Recommended as the target level for optimal hair growth potential in women with hair loss 1. This threshold was established in the context of managing diffuse androgen-dependent alopecia and chronic telogen effluvium.
≥60 ng/mL: The most recent 2023 study suggests redefining normal ferritin for hair health as ≥60 ng/mL (corresponding hemoglobin ≥13.0 g/dL), noting this is substantially higher than the level at which anemia develops (ferritin 5.1 ng/mL at Hb 12.0 g/dL) 2.
≥40 ng/mL: Clinical trial data demonstrated that women with diffuse androgen-dependent alopecia treated with antiandrogen therapy responded significantly better when ferritin was above 40 ng/mL compared to below this threshold 3.
Important Clinical Context
The controversy exists because standard laboratory "normal" ferritin ranges (typically 15-150 ng/mL) do not reflect optimal levels for hair growth. The 2019 Androgen Excess and PCOS Committee guideline highlights this discrepancy, noting that studies using ferritin <15 ng/mL or even <40 ng/mL as cutoffs for "deficiency" failed to show consistent associations with female pattern hair loss 4. However, one study found that iron supplementation in patients with ferritin <70 ng/mL did not improve hair loss 4.
Gender and Age Considerations
The evidence shows important differences:
Women (premenopausal): Most data supporting the ferritin-hair loss relationship comes from female studies. Lower ferritin levels were associated with more severe hair loss in women aged 18-45 years 4.
Women (postmenopausal): Some studies found ferritin was lower in premenopausal but not postmenopausal patients with hair loss 4.
Men: The relationship is less established. Studies in men with androgenetic alopecia show conflicting results, with recent data suggesting hair iron content (not serum ferritin) may correlate with hair diameter in early-stage male pattern baldness 5.
Clinical Application Algorithm
When evaluating hair loss:
Measure serum ferritin as part of the workup, particularly in women with diffuse hair loss 4
Target ferritin ≥60-70 ng/mL for optimal hair growth conditions 2, 1
Consider iron supplementation if ferritin <60 ng/mL, especially if:
- Disease duration <6 months (better prognosis) 2
- Patient is premenopausal female
- Other causes of hair loss have been excluded
Monitor every 3 months after supplementation to assess ferritin response and clinical improvement 2
Critical Caveats
The evidence remains insufficient to definitively recommend routine iron screening or supplementation for all hair loss patients 6. The 2017 guideline on alopecia areata concluded there was inadequate evidence to recommend screening for iron deficiency in hair loss patients 6. The 2019 PCOS Committee guideline states measurements of iron studies "may be useful to rule out and treat other conditions that may affect hair regrowth" but acknowledges the uncertain relationship between iron deficiency and female pattern hair loss 4.
Ferritin is an acute-phase reactant and can be falsely elevated in inflammatory conditions, infections, liver disease, and malignancy 7. In these situations, ferritin does not accurately reflect iron stores.
No placebo-controlled trials exist demonstrating that correcting iron deficiency specifically improves hair loss outcomes 6. The one study that attempted iron supplementation at ferritin <70 ng/mL showed no benefit 4.
Practical Recommendation
In clinical practice, when evaluating a patient with hair loss, measure serum ferritin and aim for levels ≥60 ng/mL, recognizing this represents an optimal threshold for hair growth rather than a diagnostic cutoff for iron deficiency. This approach is most evidence-based for premenopausal women with diffuse hair loss or telogen effluvium, where iron deficiency was found in 70.3% of cases in the most recent study 2. For other hair loss types (alopecia areata, male pattern baldness), the evidence is weaker but checking ferritin remains reasonable to exclude a treatable contributing factor.